Lung Cancer

© GettyImages/Mohammed Haneefa Nizamudeen

Setback for Novartis drug in advanced lung cancer trial

By Jane Byrne

Novartis reported today that a clinical trial of the drug, known as canakinumab, when combined with chemotherapy agent, docetaxel, failed to extend the lives of patients with advanced or metastatic non-small cell lung cancer compared to just chemotherapy...

(Image: iStock/kasto80)

ATCC adds novel in vitro model to expanding portfolio

By Melissa Fassbender

ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.

Lonza and Agennix form tactical alliance

Lonza and Agennix form tactical alliance

Lonza and Agennix have made a tactical alliance over the Phase III production of a non-small cell lung cancer therapy in the hopes it will improve the chance of joint manufacturing after the commerical launch.


Follow us


View more


Featured Suppliers